Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,432,844 papers from all fields of science
Search
Sign In
Create Free Account
Quisinostat
An orally bioavailable, second-generation, hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. HDAC…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Apoptosis
Chromatin Structural Process
Free Radical Formation
Gene Expression Regulation
Expand
Narrower (1)
JNJ 26481585
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract 643: The histone deacetylase inhibitor Quisinostat augments the anti-tumor reponses of T-cells: Implications in adoptive cell therapy
David M. Woods
,
Andressa L. Sodré
,
J. Brayer
,
E. Sotomayor
2014
Corpus ID: 72194346
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA It has become increasingly clear that histone deacetylases…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE